Lumos Diagnostics Holdings Limited

LDXHFOTCHealthcare● Active

$0.08

$-0.00(-5.49%)

Market Cap$59085225

P/E Ratio—

52W High$0.24

52W Low$0.0161

Avg Volume68K

Open$0.08

Beta0.54

Earnings Financials Revenue

Lumos Diagnostics Holdings Limited (LDXHF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LDXHF · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2026Report Date: Feb 26, 2026

EPS Actual

-$0.01

Revenue

$0.01B

Fiscal Period

Q1 FY2026

FY ends December

Report Date

Feb 26, 2026

After Market Close

✓ 2-Quarter EPS Beat Streak

LDXHF reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Sep 2, 2026	—	—	—	—	—	—
◌ Q3 FY2026	Sep 1, 2026	—	—	—	—	—	—
— Q1 FY2026	Feb 26, 2026	—	-$0.01	—	$0.01B	—	—
— Q2 FY2025	Jun 30, 2025	—	-$0.00	—	$0.01B	—	—
— Q4 FY2024	Dec 30, 2024	—	-$0.01	—	$0.01B	—	—
◌ Q4 FY2024	Oct 31, 2024	—	—	—	—	—	—
— Q2 FY2024	Jun 30, 2024	—	-$0.00	—	$0.01B	—	—
— Q4 FY2023	Dec 30, 2023	—	-$0.01	—	$0.00B	—	—

Q3 FY2026

Sep 2, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2026

Sep 1, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Feb 26, 2026

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q2 FY2025

Jun 30, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q4 FY2024

Dec 30, 2024

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q4 FY2024

Oct 31, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Jun 30, 2024

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q4 FY2023

Dec 30, 2023

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2026	Feb 26, 2026	—	$0.20	$0.20	+0.00%
— Q2 FY2025	Jun 30, 2025	—	$0.02	$0.02	+0.00%
— Q4 FY2024	Dec 30, 2024	—	$0.03	$0.03	+0.00%
— Q2 FY2024	Jun 30, 2024	—	$0.03	$0.03	+0.00%
— Q4 FY2023	Dec 30, 2023	—	$0.04	$0.04	+0.00%
▲ Q2 FY2023	Jun 30, 2023	+85.2%	$0.01	$0.01	+0.00%
▲ Q4 FY2022	Dec 30, 2022	+34.7%	$0.05	$0.05	+0.00%
▼ Q2 FY2022	Jun 30, 2022	-431.5%	$0.25	$0.25	+0.00%

Q1 FY2026+0.00%

Report Date

Feb 26, 2026

EPS Beat/Miss

—

Price Before

$0.20

Price After

$0.20

Q2 FY2025+0.00%

Report Date

Jun 30, 2025

EPS Beat/Miss

—

Price Before

$0.02

Price After

$0.02

Q4 FY2024+0.00%

Report Date

Dec 30, 2024

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q2 FY2024+0.00%

Report Date

Jun 30, 2024

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q4 FY2023+0.00%

Report Date

Dec 30, 2023

EPS Beat/Miss

—

Price Before

$0.04

Price After

$0.04

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

+85.2%

Price Before

$0.01

Price After

$0.01

Q4 FY2022+0.00%

Report Date

Dec 30, 2022

EPS Beat/Miss

+34.7%

Price Before

$0.05

Price After

$0.05

Q2 FY2022+0.00%

Report Date

Jun 30, 2022

EPS Beat/Miss

-431.5%

Price Before

$0.25

Price After

$0.25

Avg Beat Reaction+0.00%

Avg Miss Reaction+0.00%

Beat Rate2 / 8 quarters

Largest Move+0.00% (Q1 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Lumos Diagnostics Holdings Limited (LDXHF) most recently reported earnings on February 26, 2026 for Q1 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). LDXHF has beaten EPS estimates for 2 consecutive quarters. The next LDXHF earnings date is expected around September 1, 2026.

Each quarter, investors track LDXHF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LDXHF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

LDXHF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

LDXHF earnings · 4 questions

Lumos Diagnostics Holdings Limited's next earnings report is expected around September 1, 2026. LDXHF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LDXHF historically reports after market close (AMC).

LDXHF earnings datewhen is LDXHF earningsLDXHF next earnings datewhen does LDXHF report earningsLDXHF earnings calendar

▸ Source: FMP · Lumos Diagnostics Holdings Limited SEC filings · US GAAP · Lumos Diagnostics Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026